In SLE patients, CD8+ T cells expressed activation markers such as ICOS, CXCR5, Eomes, and T‐bet, cytotoxic and inflammatory molecules which were responsible for exacerbating the disease pathology [22, 23]. Here, CD8A is linked to systemic lupus erythematosus.